Rossari Biotech Schedules Q3 FY26 Earnings Conference Call for January 19, 2026
Rossari Biotech Limited has scheduled an earnings conference call for January 19, 2026, at 4:00 PM IST to discuss Q3 FY26 financial results with investors and analysts. The company filed this intimation under SEBI Regulation 30, with the call featuring management discussion on quarterly and nine-month results ended December 31, 2025, followed by an interactive Q&A session.
*this image is generated using AI for illustrative purposes only.
Rossari Biotech Limited has officially announced an earnings conference call to discuss its Q3 FY26 financial performance with investors and analysts. The company filed this intimation with stock exchanges under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Conference Call Details
The earnings conference call has been scheduled with specific parameters for participant access:
| Parameter: | Details |
|---|---|
| Date: | Monday, January 19, 2026 |
| Time: | 4:00 PM IST |
| Meeting Type: | Conference Call - Group Meet (Telecommunication) |
| Participants: | Investors and Analyst Groups |
| Universal Dial-in: | +91 22 6280 1141 / 7115 8042 |
Meeting Structure and Agenda
The conference call will follow a structured format designed to provide comprehensive insights into the company's quarterly performance. The session will commence with a brief management discussion covering financial results for the quarter and nine months ended December 31, 2025. Following the management presentation, an interactive Question & Answer session will allow participants to engage directly with the senior management team.
Pre-Registration and Access
To enhance participant experience, Rossari Biotech has arranged for zero wait time access through pre-registration. Participants can register in advance using the provided DiamondPass system, eliminating the need to wait for operator assistance when joining the call.
Company Background
Rossari Biotech Limited operates as a specialty chemicals manufacturer, providing intelligent and sustainable solutions across multiple industries. The Mumbai-headquartered company maintains strategically located manufacturing facilities at Silvassa and Dahej. The company's product portfolio spans Home, Personal Care and Performance chemicals (HPPC), Textile specialty chemicals, and Animal Health and Nutrition (AHN) segments.
Regulatory Compliance
The earnings call announcement was signed by Parul Gupta, Head - Company Secretary & Legal (Membership No.: A38895), and submitted to both BSE Limited and National Stock Exchange of India Limited on January 13, 2026. This filing ensures compliance with mandatory disclosure requirements for listed companies regarding investor communication activities.
Historical Stock Returns for Rossari Biotech
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -4.71% | -2.14% | -4.81% | -17.32% | -37.90% | -71.38% |
18
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
